Home » Topics » BioWorld Science

BioWorld Science
RSS

New cytochrome P450 1B1 inhibitors identfied at the University of Kentucky

Sep. 6, 2021

University of Minho chromene compound induces apoptosis in breast cancer cells

Sep. 6, 2021

BI-1265162, an inhaled ENaC inhibitor for the mutation-agnostic treatment of cystic fibrosis

Sep. 6, 2021

GeneQuantum and BrightGene collaborate on development of antibody immune agonist conjugate GQ-1007

Sep. 6, 2021

HEC-866, a novel pirfenidone analogue with improved therapeutic efficacy in models of IPF

Sep. 6, 2021

[11C]PDE7-136 as new PET neuroimaging candidate

Sep. 6, 2021

NRG gearing up for series A to advance brain-penetrant PTP inhibitors

Sep. 6, 2021

Shanghai Meiyue Biotech Development divulges transcription factor PU.1 inhibitors

Sep. 6, 2021

Glucocorticoid receptor agonist ADCs patented by AbbVie

Sep. 6, 2021

Lilly identifies new ketohexokinase inhibitors

Sep. 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...